COMPANY
Transverse Medical
Timeline
- Trial start Not phased (device or behavioral study): Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN) source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06962371 | Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN) | Not phased (device or behavioral study) | Recruiting | Apr 7, 2025 | 2026-03 (estimated) |